← Back to Search

RETAIN Program for Work-related Injuries (MN RETAIN Trial)

N/A
Recruiting
Led By Laura Breeher, MD, MPH
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

MN RETAIN Trial Summary

This trial will evaluate the impact of the RETAIN program on workforce retention and disability in MN. The program is funded by the US Department of Labor and includes collaborations between various state organizations.

Who is the study for?
The Minnesota RETAIN Phase 2 trial is for Minnesota residents who have had or will have surgery affecting their work within the last 12 weeks or next 8 weeks. Participants must have worked in MN at least one day in the past 3 months, be over 18, and employed or active in the labor force. It's not for those with worker's comp having a QRC/DCM, involved in related litigation, unable to consent, employed by certain organizations with return-to-work programs, or on SSDI/SSI.Check my eligibility
What is being tested?
This study tests the RETAIN program aimed at helping employees stay at work or return after an injury or illness. It's a randomized control trial assessing if this program can reduce workplace disability and improve workforce retention through early intervention practices implemented by various partners including Mayo Clinic and state departments.See study design
What are the potential side effects?
Since this trial involves a social support program rather than medical treatment, traditional side effects are not applicable. However, participants may experience changes in employment status due to varying effectiveness of the program interventions.

MN RETAIN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

MN RETAIN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in long term work disability
Reduction on work disability at 1 years
Workers to maintain employment

MN RETAIN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Individuals will be assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager. Intervention group participants will be referred for additional career and workforce development resources when needed.
Group II: Control GroupActive Control1 Intervention
Individuals will receive a handout with additional job related services; e.g. Job Accommodation Network.

Find a Location

Who is running the clinical trial?

Minnesota Department of Employment and Economic DevelopmentUNKNOWN
Minnesota Department of HealthOTHER_GOV
8 Previous Clinical Trials
223,963 Total Patients Enrolled
Mathematica Policy ResearchUNKNOWN

Media Library

RETAIN Program Clinical Trial Eligibility Overview. Trial Name: NCT05216016 — N/A
Work-related Injuries Research Study Groups: Control Group, Intervention Group
Work-related Injuries Clinical Trial 2023: RETAIN Program Highlights & Side Effects. Trial Name: NCT05216016 — N/A
RETAIN Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05216016 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor have any open spots for participants?

"Affirmative. Clinicaltrials.gov confirms that this study, which was originally published on December 23rd 2021 is actively looking for recruits. A total of 3200 subjects from a single location must be enrolled in the trial."

Answered by AI

What is the uppermost limit of participants for this research project?

"Affirmative. According to the information hosted on clinicaltrials.gov, this medical trial is actively recruiting participants and began doing so since December 23rd 2021. The study requires 3200 patients from one location and was last updated on April 4th 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Minnesota RETAIN Phase 2
Laura E. Breeher 2021. "Minnesota RETAIN Phase 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05216016.
~960 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top